Bacteriophage Market Size, Share, Growth Analysis, By Type(DsDNA Bacteriophage, SsDNA Bacteriophage, and SsRNA Bacteriophage), By Application(Animal Health, Agriculture, Aquaculture, Food Industry), By Region - Industry Forecast 2024-2031

The global bacteriophage market's competitive landscape is evolving rapidly with a growing number of biotech companies focusing on phage-based therapies and solutions. Established players like Adaptive Phage Therapeutics, Pherecydes Pharma, and Eligo Bioscience lead in research and development. Collaborations between pharmaceutical giants and smaller startups are driving innovation and product pipelines. Regulatory approvals and clinical trials are shaping the market's dynamics, creating opportunities for new entrants. Intellectual property rights and technology acquisitions also influence the landscape. As the antimicrobial resistance crisis intensifies, the Bacteriophage market is expected to witness intensified competition, consolidation, and increased investment in research and commercialization efforts.

Bacteriophage Market  Top Player’s Company Profile

• Microgen (U.S.)

• Micreos (Netherlands)

• ATCC (U.S.)

• Intralytix, Inc. (U.S.)

• Adaptive Phage Therapeutics (U.S.)

• Armata pharmaceuticals Inc. (U.S.)

• LOCUS BIOSCIENCES, INC. (U.S.)

• Delmont Laboratories, Inc. (U.S.)

• Nextbiotics (U.S.)

• Pherecydes Pharma (France)

• iNtODEWORLD. Inc. (U.S.)

• Enbiotix (U.S.)

• Fixed-Phage Limited (U.K.)

• Cytophage Technologies Inc. (Canada)

• Eliava Bio Preparations LTD (Georgia)

• Phagelux, Inc. (China)

• InnoPhage, Ltd (Hong Kong)

• TechnoPhage (Portugal)

• Eligo Bioscience SA (France)

• BiomX Ltd. (Israel)

Bacteriophage Market